Nouveau Life Pharmaceuticals Inc
Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in providing a platform for remote senior care. The company also enables users to monitor patients in real time and access detailed patient information digitally; and its platform is designed to detect emergencies proactively and facilitate non-face-to-face care services. In addition, the company is developing robotic and ar… Read more
Nouveau Life Pharmaceuticals Inc (NOUV) - Net Assets
Latest net assets as of March 2023: $-95.55K USD
Based on the latest financial reports, Nouveau Life Pharmaceuticals Inc (NOUV) has net assets worth $-95.55K USD as of March 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.71K) and total liabilities ($103.26K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-95.55K |
| % of Total Assets | -1238.82% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Nouveau Life Pharmaceuticals Inc - Net Assets Trend (2002–2006)
This chart illustrates how Nouveau Life Pharmaceuticals Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nouveau Life Pharmaceuticals Inc (2002–2006)
The table below shows the annual net assets of Nouveau Life Pharmaceuticals Inc from 2002 to 2006.
| Year | Net Assets | Change |
|---|---|---|
| 2006-12-31 | $315.86K | +136.36% |
| 2005-12-31 | $-868.82K | +9.52% |
| 2004-12-31 | $-960.23K | -14.34% |
| 2003-12-31 | $-839.79K | -5.10% |
| 2002-12-31 | $-799.06K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nouveau Life Pharmaceuticals Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 132774400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2006)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $30.05K | 9.51% |
| Other Comprehensive Income | $675.70K | 213.92% |
| Other Components | $2.42 Million | 765.16% |
| Total Equity | $315.86K | 100.00% |
Nouveau Life Pharmaceuticals Inc Competitors by Market Cap
The table below lists competitors of Nouveau Life Pharmaceuticals Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Quick-Med Technologies Inc
PINK:QMDT
|
$0.96 |
|
Blue Gem Enterprise
PINK:BGEM
|
$0.96 |
|
Proliance International Inc
PINK:PLNTQ
|
$0.96 |
|
Aerofoam Metals Inc
PINK:AFML
|
$0.97 |
|
Discovery Minerals
PINK:DSCR
|
$0.96 |
|
American Leisure Holdings Inc
PINK:AMLH
|
$0.96 |
|
Kunekt Corporation
PINK:KNKT
|
$0.96 |
|
CVF Technologies Corporation
PINK:CNVT
|
$0.96 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nouveau Life Pharmaceuticals Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2005 to 2006, total equity changed from -868,818 to 315,863, a change of 1,184,681.
- Net loss of 357,248 reduced equity.
- Share repurchases of 1,000,000,000,000,000,000 reduced equity.
- Other comprehensive income increased equity by 128,329.
- Other factors increased equity by 1,000,000,000,001,413,504.
Equity Change Factors (2005 to 2006)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-357.25K | -113.1% |
| Share Repurchases | $1000000.00 Trillion | -316592953274046.06% |
| Other Comprehensive Income | $128.33K | +40.63% |
| Other Changes | $1000000.00 Trillion | +316592953274493.56% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Nouveau Life Pharmaceuticals Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.01x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $-0.04 | $0.00 | x |
| 2003-12-31 | $-0.04 | $0.00 | x |
| 2004-12-31 | $-0.04 | $0.00 | x |
| 2005-12-31 | $-0.03 | $0.00 | x |
| 2006-12-31 | $0.01 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nouveau Life Pharmaceuticals Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -113.10%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 4.21x
- Recent ROE (-113.10%) is below the historical average (-22.62%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.00% | 0.00% | 0.00x | 0.00x | $-174.09K |
| 2003 | 0.00% | 0.00% | 0.00x | 0.00x | $-228.27K |
| 2004 | 0.00% | 0.00% | 0.00x | 0.00x | $-305.41K |
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-169.93K |
| 2006 | -113.10% | 0.00% | 0.00x | 4.21x | $-388.83K |
Industry Comparison
This section compares Nouveau Life Pharmaceuticals Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nouveau Life Pharmaceuticals Inc (NOUV) | $-95.55K | 0.00% | N/A | $0.96 |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |